Recently, the capital of the medical device circle has surging: Yu Yue has invested 5.6 billion yuan in the old pharmaceutical company Yunnan Baiyao; pharmaceutical giant Fosun has separately listed the medical device business separately; Mindray has rushed to the A-share market, and the market value is directly pointing to 100 billion.
The capital actions of these medical equipment enterprises will undoubtedly have a greater impact on the competitive landscape of the medical device market.
Diving merger
In the event of mutual penetration of local medicine and medical equipment, the leaps into the Yunnan Baiyao can be described as a big deal. As one of the leading companies in the medical device industry , Yu Guangming’s head, Wu Guangming, has built and owned three listed medical device companies directly or indirectly through the power of capital for more than 10 years. And Wandong Medical two listed machinery enterprises, Yu Yue has undoubtedly become a holding investment platform.
In the previous big investment of Yuyue, in 2015, it took over Wandong Medical and Shanghai Machinery Group from China Resources for 1.8 billion yuan.
In November last year, Yuyue also announced that it plans to acquire 61.62% of Shanghai Zhongyou Pharmaceutical High-Tech Co., Ltd. for 863 million yuan to enter the field of medical disinfection.
In February of this year, Yuyue acquired all the shares of German Metrax through its subsidiary in Germany, a company that develops, manufactures and markets emergency medical products .
Today, Yuyue will participate in Yunnan Baiyao for 5.6 billion yuan, which is widely concerned by medical equipment peers.
According to the annual report, Yuyue Medical's total operating income in 2016 was 2.633 billion yuan, a year-on-year increase of 25.14%; the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 489 million yuan, a year-on-year increase of 39.5%.
Fosun layout medical equipment
In the eyes of many people, Fosun is undoubtedly a mainstream pharmaceutical company. As everyone knows, when Guo Guangchang, the chairman of Fosun, first started his business, he did the in vitro diagnostic reagent and earned the first one million in his life.
After that, Fosun has made arrangements in the pharmaceutical industry, mainly participating in high-quality pharmaceutical companies, including Jiangsu Wanbang, Jinzhou Aohong, Guilin South Medicine, Chongqing Yaoyou, Shenyang Hongqi, etc., which are its main pharmaceutical industry platforms. Holding is its main pharmaceutical distribution platform.
As the pharmaceutical market enters a stable period, medical devices have become a sub-area of ​​Fosun's key development.
According to the annual report, in 2016, Fosun Pharma achieved operating income of 14.629 billion yuan, and sales of medical devices and medical diagnostics reached 2.664 billion yuan, accounting for 18.17%. The "Da Vinci Surgical Robot" of Fosun's agent has about 19,000 operations in mainland China and Hong Kong, an increase of about 54% from 2015. Even the media claimed that relying on this robot, Fosun "created 15 billion a year."
It can be seen that Fosun is about to enter the big harvest period of medical equipment, and its Israeli subsidiary will be split in Hong Kong. According to the announcement, as of the end of 2015, Sisram's total assets were 1.68 billion yuan and its net assets were 202 million yuan. In 2015, the total revenue was 685 million yuan and the net profit was 49.36 million yuan.
Sisram is a subsidiary of Fosun Pharma established in Israel in 2013. In May of that year, Fosun Pharma acquired Alma, an Israeli medical beauty equipment company, through Sisram, at a cost of US$22163 million. Fosun Pharma intends to promote Alma's IPO by the end of 2017.
With the listing of Alma, Fosun Pharma (A shares + H shares), Sinopharm and Alma will become Fosun's three listed companies in the pharmaceutical industry.
Fresh Single Packed Sweet Corn
Jilin Province Agricultural Sister-in-law Food Co., Ltd. was established in 2012 and has been in the export business since 2012. We mainly export to 16 countries all over the world.
About our main product - Corn
Corn is a kind of food that is often encountered in daily life, and it is also a kind of food to supplement the diet. Its edible benefits are as follows:
1. The fiber content of a cup of corn is 18.4% of the recommended daily amount. This helps reduce digestive problems such as constipation and hemorrhoids.
2. Corn is rich in minerals, which are beneficial to the human body in many ways.
3. Corn is a rich source of calories and is the main food in the diet of many people. The caloric content of corn is 342 calories per 100 grams, which is the highest among grains.
4. The health benefits of corn include controlling diabetes, preventing heart disease, and reducing high blood pressure.
5. Contain a lot of vitamin B group, vitamin B is called happiness factor in medicine, so eating corn can improve depression.
6. Corn not only provides necessary calories for healthy daily metabolism, but also a rich source of vitamin A, vitamin E and many minerals
If you have any questions, please contact us directly. If you have any questions, please email us directly.
Sweet Corn Cob,Yellow Sweet Corn,Sweet Corn,Fresh Corn On Cob
Jilin Province Argricultural Sister-in-law Food Co., Ltd. , https://www.nongsaocorn.com